Literature DB >> 15996197

Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression.

M J Robertson1, R S Schacterle, G A Mackin, S N Wilson, K L Bloomingdale, J Ritz, A L Komaroff.   

Abstract

Chronic fatigue syndrome (CFS) is a heterogeneous disorder of unknown aetiology characterized by debilitating fatigue, along with other symptoms, for at least 6 months. Many studies demonstrate probable involvement of the central and autonomic nervous system, as well as a state of generalized immune activation and selective immune dysfunction in patients with CFS. The aim of this study was to compare the lymphocyte subsets of patients with chronic fatigue syndrome to those of patients with major depression and multiple sclerosis as well as those of healthy control subjects. No differences were found in total numbers of T cells, B cells or natural killer (NK) cells. However, differences were found in T, B and NK cell subsets. Patients with major depression had significantly fewer resting T (CD3(+)/CD25(-)) cells than the other groups. Patients with major depression also had significantly more CD20(+)/CD5(+) B cells, a subset associated with the production of autoantibodies. Compared to patients with multiple sclerosis, patients with CFS had greater numbers of CD16(+)/CD3(-) NK cells. Further study will be required to determine whether these alterations in lymphocyte subsets are directly involved in the pathophysiology of these disorders, or are secondary effects of the causal agent(s).

Entities:  

Mesh:

Year:  2005        PMID: 15996197      PMCID: PMC1809442          DOI: 10.1111/j.1365-2249.2005.02833.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  63 in total

1.  The ontogeny and functional characteristics of human B-1 (CD5+ B) cells.

Authors:  N M Bhat; A B Kantor; M M Bieber; A M Stall; L A Herzenberg; N N Teng
Journal:  Int Immunol       Date:  1992-02       Impact factor: 4.823

2.  Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome.

Authors:  A M Bakheit; P O Behan; T G Dinan; C E Gray; V O'Keane
Journal:  BMJ       Date:  1992-04-18

Review 3.  Is chronic fatigue syndrome an infectious disease?

Authors:  A C Mawle; M Reyes; D S Schmid
Journal:  Infect Agents Dis       Date:  1993-10

4.  The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group.

Authors:  K Fukuda; S E Straus; I Hickie; M C Sharpe; J G Dobbins; A Komaroff
Journal:  Ann Intern Med       Date:  1994-12-15       Impact factor: 25.391

5.  Relationships between increased haptoglobin plasma levels and activation of cell-mediated immunity in depression.

Authors:  M Maes; S Scharpé; H Y Meltzer; P Cosyns
Journal:  Biol Psychiatry       Date:  1993-11-15       Impact factor: 13.382

6.  Prevalence of human herpesvirus 6 variants A and B in patients with chronic fatigue syndrome.

Authors:  S Yalcin; H Kuratsune; K Yamaguchi; T Kitani; K Yamanishi
Journal:  Microbiol Immunol       Date:  1994       Impact factor: 1.955

7.  Lymphocyte phenotype and function in the chronic fatigue syndrome.

Authors:  S E Straus; S Fritz; J K Dale; B Gould; W Strober
Journal:  J Clin Immunol       Date:  1993-01       Impact factor: 8.317

8.  Immunological abnormalities in patients with chronic fatigue syndrome.

Authors:  U Tirelli; G Marotta; S Improta; A Pinto
Journal:  Scand J Immunol       Date:  1994-12       Impact factor: 3.487

9.  SPECT imaging of the brain: comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex, and major unipolar depression.

Authors:  R B Schwartz; A L Komaroff; B M Garada; M Gleit; T H Doolittle; D W Bates; R G Vasile; B L Holman
Journal:  AJR Am J Roentgenol       Date:  1994-04       Impact factor: 3.959

10.  Sleep disturbance in chronic fatigue syndrome.

Authors:  L B Krupp; L Jandorf; P K Coyle; W B Mendelson
Journal:  J Psychosom Res       Date:  1993-05       Impact factor: 3.006

View more
  34 in total

1.  Rapid Fractionation and Isolation of Whole Blood Components in Samples Obtained from a Community-based Setting.

Authors:  Amy Weckle; Allison E Aiello; Monica Uddin; Sandro Galea; Rebecca M Coulborn; Richelo Soliven; Helen Meier; Derek E Wildman
Journal:  J Vis Exp       Date:  2015-11-30       Impact factor: 1.355

2.  Early immune outcome of retroperitoneal laparoscopic radical nephrectomy for localized renal cell carcinoma: a prospective, randomized study.

Authors:  Yang Lu; Fan Tianyong; Wei Qiang; Cui Xiaobo; Bu Siyuan; Han Ping
Journal:  Can Urol Assoc J       Date:  2011-11-02       Impact factor: 1.862

3.  A nanoelectronics-blood-based diagnostic biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

Authors:  R Esfandyarpour; A Kashi; M Nemat-Gorgani; J Wilhelmy; R W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-29       Impact factor: 11.205

4.  Levels of lymphocyte subsets in peripheral blood prior treatment are associated with aggressive breast cancer phenotypes or subtypes.

Authors:  Yijun Jia; Lei Xu; Qing Lin; Mingjie Zhu; Longlong Ding; Kejin Wu; Yunshu Lu
Journal:  Med Oncol       Date:  2014-05-06       Impact factor: 3.064

5.  A systematic review of chronic fatigue syndrome: don't assume it's depression.

Authors:  James P Griffith; Fahd A Zarrouf
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

6.  Altered B Cell Homeostasis in Patients with Major Depressive Disorder and Normalization of CD5 Surface Expression on Regulatory B Cells in Treatment Responders.

Authors:  Diana Ahmetspahic; Kathrin Schwarte; Oliver Ambrée; Christian Bürger; Vladislava Falcone; Katharina Seiler; Mehrdad Rahbar Kooybaran; Laura Grosse; Fernand Roos; Julia Scheffer; Silke Jörgens; Katja Koelkebeck; Udo Dannlowski; Volker Arolt; Stefanie Scheu; Judith Alferink
Journal:  J Neuroimmune Pharmacol       Date:  2017-09-13       Impact factor: 4.147

7.  Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series.

Authors:  Øystein Fluge; Olav Mella
Journal:  BMC Neurol       Date:  2009-07-01       Impact factor: 2.474

Review 8.  Contributions of the adaptive immune system to mood regulation: Mechanisms and pathways of neuroimmune interactions.

Authors:  Miles Herkenham; Stacey L Kigar
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2016-09-06       Impact factor: 5.067

9.  Longitudinal associations of lymphocyte subsets with clinical outcomes in chronic fatigue syndrome.

Authors:  Melissa L Mehalick; Karen B Schmaling; Daniel E Sabath; Dedra S Buchwald
Journal:  Fatigue       Date:  2018-01-12

10.  Immune and hemorheological changes in chronic fatigue syndrome.

Authors:  Ekua W Brenu; Donald R Staines; Oguz K Baskurt; Kevin J Ashton; Sandra B Ramos; Rhys M Christy; Sonya M Marshall-Gradisnik
Journal:  J Transl Med       Date:  2010-01-11       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.